Adulterated and Misbranded: Inaccurate Labeling (Cannabinoid inflation)
The Department of Cannabis Control (DCC) is issuing this notice of voluntary recall for a single Mary's Medicinal Transdermal Compound Topical product(s) due to the presence of Inaccurate Labeling (Cannabinoid inflation).
This recall applies to the following Mary's Medicinal Transdermal Compound Topical product:
If you purchased this product:
DCC sent notices to all licensees with this product in their inventory with instructions about responding to this recall. Contact our team at recalls@cannabis.ca.gov if you have any questions.